Glioblastoma Clinical Trials Database - Free Access to 405 Studies
Access comprehensive clinical trial information for Glioblastoma through Pure Global AI's free database. This collection includes 405 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 93 trials are actively recruiting participants.
Research for Glioblastoma is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include Massachusetts General Hospital and Dana-Farber Cancer Institute. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy
A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma
Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)
Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
Glioblastoma Psychosocial Support Program
Predictive Value of Soluble CD146 in Glioblastoma Patients
Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma
Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma
Clinical Trial of the ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Recurrent Brain Tumors
Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
Investigating the impact of a Neuro-Oncology nurse home visiting service in the management of patients with glioblastoma
Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.
B-amyloid as a Marker for GBM Bioimaging
Pure Global AI provides free access to 405 clinical trials studying Glioblastoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Massachusetts General Hospital, Dana-Farber Cancer Institute, Grupo Español de Investigación en Neurooncología, among others.